Nervous Necrosis Virus

Overview and Taxonomy of Nervous Necrosis Virus

The Nervous Necrosis Virus (NNV) stands as one of the most formidable viral pathogens confronting global aquaculture, representing a persistent and economically devastating threat to both marine and freshwater finfish production. The disease it causes, Viral Nervous Necrosis (VNN) or Viral Encephalopathy and Retinopathy (VER), is characterized by a profound neurotropism leading to severe vacuolative lesions within the central nervous system (CNS) and retina, culminating in characteristic behavioural abnormalities and mass mortality events, particularly in larval and juvenile stages [2, 13, 27]. The global impact of NNV is immense, with documented susceptibility in over 120 to 200 fish species, encompassing a wide phylogenetic and ecological range that extends from temperate to tropical waters and across both wild and cultured populations [1, 5, 6, 8, 12]. The pathogen’s capacity to cause up to 100% mortality in affected hatcheries and nursery facilities has positioned it as a primary obstacle to the sustainable intensification of marine aquaculture, a sector already critical to global food security [8, 9, 26]. Its significance is formally recognized by the World Organisation for Animal Health (WOAH), which lists NNV infection as a notifiable disease due to its severe socio-economic consequences and potential for transboundary spread.

From a taxonomic perspective, NNV is the archetypal member of the genus Betanodavirus within the family Nodaviridae. This family is characterized by small, non-enveloped, icosahedral virions with a diameter of approximately 25–30 nm, a morphology consistently observed through transmission electron microscopy (TEM) of infected tissues and purified viral particles [26, 27, 29]. The viral genome comprises a bipartite, positive-sense, single-stranded RNA ((+)ssRNA) molecule, a feature that places it within the Baltimore class IV group of RNA viruses. The two genomic segments are designated RNA1 and RNA2. RNA1, which is approximately 3.1 kb in length, encodes the viral RNA-dependent RNA polymerase (RdRp), also referred to as Protein A, which is the essential catalytic engine for viral genome replication and transcription [10, 12, 15]. RNA2, the smaller segment at approximately 1.4 kb, encodes the viral capsid protein (CP), the sole structural protein that assembles into the icosahedral capsid and mediates critical interactions with the host cell, including receptor binding and entry [1, 4, 10]. A sub-genomic transcript, RNA3, is derived from the 3' terminus of RNA1 during replication and encodes non-structural proteins B1 and B2. These accessory proteins are not incorporated into virions but play essential roles in viral pathogenesis, particularly in antagonizing the host interferon (IFN) response and facilitating viral replication, often by targeting host transcriptional machinery [8, 11, 14, 24].

Historically, NNV isolates were differentiated based on their host species of origin, leading to a proliferation of names such as Striped Jack Nervous Necrosis Virus (SJNNV), Red-Spotted Grouper Nervous Necrosis Virus (RGNNV), Barfin Flounder Nervous Necrosis Virus (BFNNV), and Tiger Puffer Nervous Necrosis Virus (TPNNV) [18-21, 33]. The modern and definitive taxonomic framework, however, is based on phylogenetic analysis of the variable region of the capsid protein gene (RNA2). This molecular approach delineates four major recognized genotypes, or species, within the genus Betanodavirus: RGNNV, SJNNV, BFNNV, and TPNNV [3, 12, 16]. The nucleotide sequence divergence between these genotypes is substantial, often exceeding 20% in the RNA2 segment, which correlates with distinct biological properties, notably optimal replication temperatures and host range. RGNNV, for instance, is the most prevalent and virulent genotype globally, thriving at higher water temperatures (25–30°C) and infecting a remarkably broad spectrum of warm-water marine fish, particularly groupers (Epinephelus spp.), European sea bass (Dicentrarchus labrax), and barramundi (Lates calcarifer) [8, 10, 24, 26]. Conversely, BFNNV is adapted to cold-water environments, such as those inhabited by flounder and Atlantic cod, replicating optimally at temperatures around 15–20°C [3, 18]. SJNNV has a more restricted host range, originally isolated from striped jack (Pseudocaranx dentex), while TPNNV was first identified in tiger puffer (Takifugu rubripes) [17, 19].

The taxonomic landscape is further complicated, and continuously evolving, due to the bipartite nature of the NNV genome, which allows for the generation of natural reassortant strains. Co-infection of a single host with two distinct genotypes can lead to progeny viruses harboring an RNA1 segment from one genotype and an RNA2 segment from another. The most epidemiologically significant reassortants are those combining the RNA1 of RGNNV with the RNA2 of SJNNV (designated RGNNV/SJNNV) or, less commonly, the reciprocal reassortant [22, 25, 31, 34]. These reassortant strains often exhibit novel pathogenic properties, bridging host and environmental preferences of their parents. For example, the RGNNV/SJNNV reassortant has emerged as a major threat to gilthead sea bream (Sparus aurata) in the Mediterranean, a species previously considered resistant to the parental RGNNV genotype [22, 34]. This highlights the dynamic nature of NNV evolution and the critical importance of molecular surveillance for identifying emerging strains. Beyond the canonical four genotypes, ongoing surveillance continues to reveal novel or divergent NNV lineages. Recent studies have documented a novel genotype in black sea bass (Centropristis striata) off the US Atlantic coast, tentatively named Black Sea Bass Nervous Necrosis Virus (BSBNNV), and another unique genotype circulating among Nile tilapia (Oreochromis niloticus) in Egypt, underscoring that the known genetic diversity of NNV is likely incomplete and that new genotypes continue to emerge in both established and novel aquaculture settings [3, 9].

The viral architecture of the NNV capsid is central to its biology and pathogenesis. The capsid protein (CP) self-assembles into a T=3 icosahedral structure, composed of 180 monomers arranged as 90 dimeric protrusions on the virion surface [16, 28, 30]. The CP is a multi-domain protein. Its N-terminal region is rich in arginine residues and is believed to interact with the genomic RNA within the capsid interior, playing a critical role in encapsidation. The central region forms the shell (S) domain, which constitutes the continuous protein shell of the virion. The C-terminal region forms the protruding (P) domain, which is exposed on the surface of the viral particle and constitutes the major antigenic site [16, 30]. These surface protrusions are the primary targets of neutralizing antibodies and are also responsible for binding to host cellular receptors, a functional duality that significant research suggests may be spatially and structurally separated. Studies investigating the differential loss of antigenicity and infectivity under various physicochemical treatments (such as heat, pH, and urea) provide strong evidence that the binding sites for neutralizing antibodies and cellular receptors are distinct and independently located on these surface protrusions [16, 30, 32].

The interplay of these structural and genetic features defines NNV as a sophisticated and highly adaptive pathogen. Its bipartite genome facilitates reassortment, driving the emergence of strains with unpredictable host ranges and virulence. The structural integrity of its capsid, particularly the surface protrusions, is the lynchpin for cell entry and immune evasion. The continuous discovery of new genotypes and the global spread of highly virulent reassortants, such as RGNNV/SJNNV, present immense challenges for developing universal vaccines and implementing effective biosecurity measures. A deep, multi-layered understanding of NNV taxonomy, from the genomic and capsid levels to the ecological and biogeographic dynamics of its genotypes, is therefore an absolute prerequisite for rational disease management, the development of broad-spectrum prophylactics, and the design of selective breeding programs aimed at enhancing host resistance in the face of this persistent and evolving viral threat [7, 23, 25, 28].

Molecular Virology and Genomic Organization of Nervous Necrosis Virus

Nervous necrosis virus (NNV), the aetiological agent of viral nervous necrosis (VNN) or viral encephalopathy and retinopathy (VER), represents one of the most formidable viral pathogens confronting global aquaculture. Recognized by the World Organisation for Animal Health (WOAH) as a notifiable pathogen of significant socioeconomic consequence, NNV is responsible for catastrophic epizootics that can decimate larval and juvenile populations of over 200 marine and freshwater fish species, with mortality rates frequently approaching 100% [5, 6, 9, 25]. The virus belongs to the family Nodaviridae, genus Betanodavirus, and is characterized by a remarkably simple virion architecture that belies a sophisticated and highly pathogenic molecular machinery [1, 12, 16]. Understanding the molecular architecture and genomic strategy of NNV is fundamental to elucidating its neurotropism, immune evasion tactics, and capacity for rapid evolution, all of which are critical for the development of effective countermeasures, including vaccines and antiviral therapeutics.

Genomic Architecture: A Bipartite Positive-Sense RNA Genome

The NNV genome is meticulously organized as a bipartite, single-stranded, positive-sense RNA molecule, the simplest arrangement among viruses capable of causing systemic neurological disease [10, 12, 42]. The genome is divided into two essential segments, designated RNA1 and RNA2, which are co-packaged within an icosahedral, non-enveloped virion approximately 25–35 nm in diameter [26, 27].

RNA1 is the larger of the two segments, typically ranging from approximately 3.1 kb in length. This segment serves as the primary genetic repository for the viral replication machinery, encoding the RNA-dependent RNA polymerase (RdRp), also referred to as Protein A [1, 10, 15]. The RdRp is the central enzymatic component responsible for replicating the viral genome and transcribing subgenomic mRNA. It is a multi-functional enzyme that orchestrates the synthesis of both negative-sense replicative intermediates and new positive-sense genomic strands within the cytoplasm of the host cell. Critically, RNA1 also functions as a template for the synthesis of a subgenomic RNA, RNA3, which is a hallmark of betanodavirus replication strategy [11, 24].

RNA2, which is approximately 1.4 kb in length, encodes a single structural protein: the capsid protein (CP) [1, 10, 15, 29]. The CP is the only structural component of the virion, responsible for encapsidating the genomic RNA and mediating viral entry into host cells. It is a highly multifunctional protein, as it is not merely a passive shell but an active participant in nearly every stage of the viral life cycle, including host receptor recognition, attachment, entry, intracellular trafficking, and the manipulation of host cellular processes to favour viral replication [4, 35, 38].

The Subgenomic RNA3 and the Non-Structural B1 and B2 Proteins

A defining and highly consequential feature of the NNV replication cycle is the production of RNA3, a subgenomic transcript synthesized from the 3' terminus of RNA1 [11, 24]. This small, non-encapsidated RNA molecule is produced during viral replication and encodes two small, non-structural proteins: B1 and B2. The existence of RNA3 and its protein products represents a sophisticated viral strategy to expand the coding capacity of the compact genome, enabling the virus to exert fine-tuned control over the host cellular environment [8, 11, 24].

The B2 protein is an early and potent viral antagonist of host antiviral immunity. It is expressed very early in the infection cycle, detectable as soon as 3 hours post-infection, well before the structural capsid protein accumulates [11]. B2 acts as a dedicated suppressor of the host interferon (IFN) system. Mechanistically, B2 has been demonstrated to function as a general inhibitor of host transcription by directly targeting and destabilizing the RNA polymerase II (RNAP II) complex. It achieves this by diminishing the levels of Ser5-phosphorylated RNAP II, a modification essential for transcriptional initiation and elongation [8, 24]. By crippling the host's transcriptional capacity, B2 effectively silences the expression of IFN and interferon-stimulated genes (ISGs), creating a permissive intracellular environment for unchecked viral replication. This strategy allows B2 to block the antiviral signalling cascade initiated by key RIG-I-like receptor (RLR) pathway components, including MDA5, MAVS, TBK1, IRF3, and IRF7 [8, 24].

The B1 protein, in contrast, has been less extensively characterized but is emerging as an equally critical factor in host manipulation. Recent evidence indicates that B1 also functions as a transcription inhibitor, specifically targeting the host IFN response [8]. Similar to B2, B1 appears to act by suppressing the activity of the RNAP II complex, thereby inhibiting the production of IFN and ISGs. The presence of two independent viral proteins that converge on the same essential host process, the shutdown of RNAP II-dependent transcription, underscores the absolute necessity for NNV to neutralize the host's transcriptional antiviral defence to establish a productive infection. This functional redundancy highlights a critical vulnerability in the host that NNV has evolved to exploit with remarkable efficiency [8, 24].

Capsid Protein: The Molecular Key to Neurotropism and Pathogenesis

The capsid protein is the central orchestrator of NNV cellular tropism and pathogenesis. It is a 42-kDa protein that initially assembles into pentameric and hexameric capsomers, which subsequently form a T=3 icosahedral shell of 180 subunits, presenting characteristic surface protrusions that are critical for receptor binding and antigenicity [16, 27, 28]. The CP is not a monolithic structure; its functions are compartmentalized into distinct domains. The shell (S) domain forms the contiguous core of the capsid, while the protrusion (P) domain, which extends outward, is the primary determinant of host-cell receptor recognition and antibody neutralization [16, 35].

The CP mediates viral entry into target cells by interacting with a specific panel of host cell surface receptors. A landmark discovery in NNV virology was the identification of Nectin1 (PVRL4), an immunoglobulin-like cell adhesion molecule, as a critical functional receptor for red-spotted grouper NNV (RGNNV) [35]. Nectin1 is particularly abundant in neural tissues, which directly correlates with the profound neurotropism of NNV. The interaction involves a direct binding event between the IgC1 loop of host Nectin1 and the P-domain of the viral CP, an interaction that is essential for viral attachment and subsequent entry [35]. This receptor engagement is followed by internalization, and subsequent studies have identified Heat Shock Protein 90ab1 (HSP90ab1) as another key component of the receptor complex. HSP90ab1 acts as a co-receptor or entry factor that facilitates viral internalization via clathrin-mediated endocytosis [36, 39]. The CP has been shown to bind to the NM domain of HSP90ab1, and this interaction is essential for initiating the internalization process [36].

Once inside the cell, the CP continues to manipulate the host environment. It has been unequivocally demonstrated that the CP is the principal viral effector responsible for inducing the hallmark pathology of NNV infection: the formation of large, cytoplasmic vacuoles [5, 13, 37]. The CP triggers a complex and incomplete autophagic response, characterized by autophagosome formation but an impairment of subsequent autophagosome-lysosome fusion [36, 41]. This process involves the CP binding to HSP90ab1 and competitively inhibiting the HSP90ab1-AKT interaction, thereby inactivating the AKT-MTOR signalling pathway and inducing autophagy [36]. Further, the CP induces vacuolization that is a Rab5- and actin-dependent process, connecting viral entry and replication to the host's endocytic and cytoskeletal machinery [5].

Perhaps the most devastating molecular activity of the CP is its capacity to induce a global host translation shutoff. NNV infection leads to a dramatic suppression of host protein synthesis, a strategy to monopolize the cellular translational machinery for viral protein production. The CP is directly responsible for this phenomenon. It achieves this by binding to the host translation factor, polyadenylate binding protein (PABP), and triggering its nuclear translocalization and subsequent degradation via the ubiquitin-proteasome pathway [38]. This degradation of a key translation initiation factor effectively starves the host cell of its ability to synthesize new proteins, including those required for antiviral defence. The CP also actively subverts the innate immune system at a higher level. It has been shown to target cyclic GMP-AMP synthase (cGAS), a cytosolic DNA sensor, for ubiquitination and degradation, thereby dampening the cGAS-mediated interferon signalling pathway, a novel mechanism of immune evasion by an RNA virus [4].

Genetic Diversity, Quasispecies, and Reassortment

The molecular virology of NNV is further complicated by its high genetic plasticity. NNV, as an RNA virus with an error-prone RdRp, exists as a dynamic population of closely related but genetically distinct variants, known as a quasispecies [10, 31]. This genetic heterogeneity allows the virus to rapidly adapt to selective pressures, such as the host immune response or a change in host species. The existence of a quasispecies has been directly linked to virulence; subtle changes in the mutant spectrum can dramatically alter the pathogenic potential of the viral population [10]. A single amino acid substitution at position 270 of the capsid protein, for instance, has been identified as a major determinant of virulence in both the RGNNV genotype and RGNNV/SJNNV reassortants [10, 34].

A particularly significant source of genetic innovation in NNV is reassortment. Since the genome is segmented, co-infection of a single cell with two different NNV strains can lead to the exchange of genomic segments, producing a novel reassortant virus. The most epidemiologically important reassortants are those combining the RNA1 segment from RGNNV with the RNA2 segment from striped jack nervous necrosis virus (SJNNV), the so-called RGNNV/SJNNV genotype [22, 31, 34, 40]. These reassortants have demonstrated altered virulence profiles and host ranges. For example, the RGNNV/SJNNV genotype has been shown to be highly pathogenic to gilthead sea bream (Sparus aurata), a species previously considered relatively resistant to NNV [22]. This capacity for reassortment, combined with a high mutation rate, allows NNV to constantly generate new genotypes and strains, including novel genotypes reported from geographically distinct regions such as the black sea bass nervous necrosis virus (BSBNNV) in the U.S. Atlantic coast and a distinct genotype in Nile tilapia from Egypt [3, 9]. These mechanisms ensure that NNV remains a dynamic and persistent threat to global aquaculture, requiring continuous surveillance and the development of broadly protective vaccines targeting conserved viral elements.

Molecular Pathogenesis and Host Immune Responses

Nervous necrosis virus (NNV), a member of the genus Betanodavirus within the family Nodaviridae, represents one of the most formidable viral pathogens confronting global aquaculture. The virus is the aetiological agent of viral nervous necrosis (VNN) or viral encephalopathy and retinopathy (VER), a disease that has been reported by the World Organisation for Animal Health (WOAH) as a significant threat to marine and freshwater fish production worldwide. The molecular pathogenesis of NNV is a complex, multi-stage process that begins with host cell attachment and culminates in a sophisticated arms race between viral evasion strategies and the host’s innate and adaptive immune systems. The virus’s bipartite positive-sense single-stranded RNA genome, comprising RNA1 (encoding the RNA-dependent RNA polymerase, RdRp, and a subgenomic RNA3 encoding the B1 and B2 non-structural proteins) and RNA2 (encoding the capsid protein, CP), provides a limited but highly efficient toolkit for subverting host cellular machinery. Understanding the precise molecular interactions that govern NNV entry, replication, vacuolization, and immune modulation is critical for developing rational control strategies, including vaccines and antiviral therapeutics.

Viral Entry and Receptor-Mediated Internalization

The initial step in NNV pathogenesis is the attachment and entry into susceptible host cells, a process that is exquisitely dependent on the interaction between the viral capsid protein (CP) and specific host cell surface receptors. The CP is the sole structural protein of NNV, and its surface protrusions are critical for both infectivity and antigenicity [16]. Recent research has identified several key host factors that mediate this process. Nectin1, a single-transmembrane glycoprotein abundant in neural tissues, has been identified as a functional receptor for red-spotted grouper NNV (RGNNV) [35]. This protein directly interacts with the CP, specifically through the binding of the IgC1 loop of Nectin1 to the P-domain of the CP, facilitating the rapid capture of free virions and subsequent viral entry [35]. This interaction is remarkably efficient, allowing non-permissive cells expressing Nectin1 to internalize virions within minutes, even at low temperatures, underscoring its role as a high-affinity attachment receptor [35].

Beyond Nectin1, the heat shock protein 90ab1 (HSP90ab1) has been characterized as a critical component of the NNV receptor complex. In marine medaka, MmHSP90ab1 binds directly to the linker region (LR) of the CP via its NM domain, acting as an attachment receptor [39]. Importantly, HSP90ab1 does not function in isolation; it forms a complex with the CP and heat shock cognate protein 70 (HSC70), another known NNV receptor [39]. This multi-receptor complex then facilitates viral internalization via clathrin-mediated endocytosis, a process dependent on the interaction between HSP90ab1 and the clathrin heavy chain [39]. The functional redundancy and cooperation between these receptors, Nectin1, HSP90ab1, and HSC70, highlight the virus’s evolved strategy to ensure efficient entry into its target cells, particularly those of the central nervous system (CNS). The gill has been identified as the primary portal of entry during water-borne infection, with the virus subsequently trafficking to the brain, where it crosses the blood-brain barrier to establish a productive infection [50].

Cytoplasmic Vacuolization and Autophagy Dysregulation

A hallmark of NNV infection is the formation of extensive cytoplasmic vacuolization in infected cells, particularly in the brain and retina, which is directly correlated with the clinical signs of neurological dysfunction [2, 5, 13]. This vacuolization is not a passive consequence of cell death but an active, virus-driven process. Live-cell imaging has revealed that vacuole formation is a Rab5- and actin-dependent process [5]. Rab5, a marker of early endosomes, continuously localizes to vacuoles bearing RGNNV particles, and its activity is essential for the formation of the characteristic giant vacuoles (>3 μm in diameter) [5]. Furthermore, actin forms distinct rings around nascent small vacuoles, and chemical inhibition of actin polymerization, but not microtubule depolymerization, significantly blocks vacuole formation [5]. This suggests that NNV hijacks the early endocytic pathway and the actin cytoskeleton to create a specialized replicative niche.

Concurrently, NNV is a potent inducer of autophagy, an evolutionarily conserved cellular degradation process. The virus triggers autophagosome formation in fish cells as early as 1.5 to 3 hours post-infection [36, 41]. This induction is mediated by the CP binding to HSP90ab1, which inactivates the HSP90ab1-AKT-MTOR pathway, leading to the dephosphorylation of mTOR and subsequent activation of autophagy [36]. However, NNV-induced autophagy is incomplete; the virus impairs the fusion of autophagosomes with lysosomes, preventing the degradation of viral components [36]. This blockade creates a protected environment where the virus can utilize autophagic membranes to enhance its own replication [41]. The activation of eIF2α phosphorylation and inhibition of mTOR are key signaling events in this process [41]. The non-structural protein B2, an early expressed protein detectable within 3 hours of infection, also plays a role in enhancing viral proliferation, potentially by modulating the early stages of replication and the cellular environment [11].

Host Translation Shutoff and Transcriptional Hijacking

NNV employs a sophisticated strategy to commandeer the host cell’s protein synthesis machinery, effectively shutting off host translation to prioritize viral protein production. The CP is the primary effector of this process. It directly binds to the host polyadenylate binding protein (PABP), a critical factor for mRNA translation and stability [38]. This interaction triggers the nuclear translocalization of PABP, removing it from the cytoplasm where it is needed for translation. In later stages of infection, the CP promotes the degradation of PABP via the ubiquitin-proteasome pathway, ensuring a complete and irreversible shutoff of host protein synthesis [38]. This mechanism is a powerful virulence factor, allowing NNV to monopolize the cellular translational apparatus.

In parallel, the non-structural proteins B1 and B2 act as potent transcriptional inhibitors to suppress the host antiviral response. The B1 protein of RGNNV functions as a general transcription inhibitor by targeting the Ser5-phosphorylated form of RNA polymerase II (RNAP II) C-terminal domain (CTD) [8]. By reducing the levels of this active form of RNAP II, B1 broadly suppresses host gene transcription, including the production of interferon (IFN) and IFN-stimulated genes (ISGs) [8]. Similarly, the B2 protein also negatively regulates host transcription directed by RNAP II, thereby blocking the IFN-mediated antiviral response [24]. This dual-pronged attack on both translation (via CP) and transcription (via B1 and B2) ensures that NNV effectively cripples the host’s ability to mount a rapid and effective immune response.

Subversion of Innate Immune Signaling Pathways

The innate immune system, particularly the type I interferon (IFN) response, is the first line of defense against viral infection. NNV has evolved multiple, overlapping mechanisms to evade and subvert this pathway, targeting key signaling nodes from the cytosolic sensors to the transcription factors.

Targeting the cGAS-STING and RLR Pathways

While cGAS (cyclic GMP-AMP synthase) is traditionally known as a DNA sensor, recent work has demonstrated its critical role in the anti-NNV response in grouper. Overexpression of Epinephelus coioides cGAS (EccGAS) inhibits NNV replication by activating the IFN signaling cascade, including TBK1 phosphorylation, IRF3 nuclear translocation, and ISG induction [4]. To counter this, NNV employs a dynamic regulatory mechanism. The CP interacts with EccGAS and promotes its polyubiquitination (via K48 and K63 linkages) in an EcUBE3C-dependent manner, leading to EccGAS degradation [4]. Conversely, the viral Protein A (ProA) binds to EccGAS and inhibits its ubiquitination and degradation, providing a protective effect [4]. The net result is that the CP’s degradative action dominates, allowing NNV to successfully evade cGAS-mediated immune surveillance [4].

The RIG-I-like receptor (RLR) pathway is another primary target. The E3 ubiquitin ligase RNF114 from sea perch (LjRNF114) is hijacked by NNV to suppress this pathway. NNV infection upregulates LjRNF114, which then targets the key signaling molecules MAVS and TRAF3 for K27- and K48-linked ubiquitination and proteasomal degradation [49]. This effectively shuts down the signaling cascade from the RLR sensors to IFN production. Similarly, the E3 ligase RNF34 is recruited by the NNV CP to target TBK1 and IRF3 for ubiquitination and degradation, further crippling the IFN response [44]. This demonstrates a convergent viral strategy: using host E3 ubiquitin ligases to degrade critical components of the antiviral signaling machinery.

Modulation of Interferon Regulatory Factors and Inflammasomes

NNV also directly manipulates the activity of interferon regulatory factors (IRFs). While IRF3 and IRF7 are essential for IFN production and are upregulated in response to NNV infection [54], the virus actively works to suppress their function. The B2 protein inhibits the promoter activity of IFNφ1 stimulated by IRF3 and IRF7 [24]. Furthermore, the host protein TRAF4, which is upregulated by NNV infection, interacts with the CP and acts as a proviral factor by inhibiting the activation of IFN, ISRE, and NF-κB, thereby suppressing the expression of IFN-related molecules and pro-inflammatory factors [48].

The NLR family CARD domain-containing protein 3 (NLRC3) represents a unique host factor that NNV manipulates to its advantage. In primary grouper brain cells, NNV infection upregulates NLRC3, which then attenuates the antiviral IFN response by impacting the TRAF6/NF-κB axis [45]. Paradoxically, NLRC3 also activates the inflammasome response and pro-inflammatory gene expression [45]. This dual role suggests that NNV uses NLRC3 to dampen the protective IFN response while simultaneously driving a potentially damaging inflammatory response, creating a favorable environment for viral replication [45]. The delicate balance between protective immunity and immunopathology is further highlighted by transcriptome analyses of resistant versus susceptible fish. In resistant leopard coral groupers, pathways related to neuroprotection and repair (e.g., neuroactive ligand-receptor interaction) are upregulated, while the NF-κB signaling pathway is downregulated in susceptible fish, suggesting that suppressing hyperactive inflammation is a key component of resistance [2].

Apoptosis, Cellular Stress, and the p53 Pathway

The interplay between NNV and host cell death pathways is complex. NNV infection induces apoptosis, and the virus has mechanisms to both promote and inhibit this process. The capsid protein can trigger apoptosis, and the host microRNA cal-miR-155, which is significantly upregulated during NNV infection, acts as a pro-apoptotic factor to inhibit virus replication [47]. Conversely, the virus can also inhibit apoptosis to prolong the survival of its host cell. The p53 signaling pathway, a critical regulator of apoptosis and cell cycle arrest, is repressed during RGNNV infection in sea perch brain cells [51]. This repression is mediated by the upregulation of Mdm2, which targets p53 for degradation [51]. Overexpression of p53 inhibits NNV replication by promoting apoptosis and enhancing the type I IFN response, indicating that NNV’s suppression of p53 is a key immune evasion strategy [51].

Cellular stress responses also play a role. Cyclophilin A (CypA), a ubiquitously expressed protein involved in inflammation, is upregulated during RGNNV infection and acts as a host restriction factor. Overexpression of CypA inhibits NNV replication, while its knockdown enhances it, an effect associated with the modulation of pro-inflammatory cytokines like TNF-α and IL-1β [53]. This highlights the host’s attempt to use inflammatory signaling to control the infection, a response that NNV must constantly counteract.

Adaptive Immunity and the Role of B and T Cells

While the innate immune response is critical for early control, the adaptive immune system is essential for long-term protection and viral clearance. NNV infection elicits both humoral and cell-mediated immune responses. The capsid protein is a major immunogen, and neutralizing antibodies against the CP are a key correlate of protection [6, 23, 43]. Oral administration of specific yolk antibodies (IgY) against the CP can neutralize the virus, reduce viral loads in the brain and eyes, and decrease the expression of immune-related factors like TNF-α, IFN-h, and IL-1β, thereby mitigating tissue pathology [43]. Similarly, virus-like particle (VLP) vaccines stimulate the production of high titers of neutralizing and specific antibodies that persist for months, although passive immunization experiments suggest that other immune mechanisms, such as cellular immunity, are also crucial for protection [23].

The cellular arm of the adaptive response involves T lymphocytes. In olive flounder, CD4-positive T lymphocytes, particularly the CD4-2 subset, increase significantly during NNV infection and are thought to play a role analogous to mammalian helper T cells in orchestrating the Th1 immune response [52]. Bicistronic DNA vaccines encoding both the CP and IRF3 have been shown to recruit lymphocytes to the injection site, significantly increase the percentage of sIgM+ B lymphocytes in the head kidney and spleen, and upregulate immune-related genes, leading to high relative percent survival rates after challenge [46]. These findings underscore the importance of a coordinated adaptive response involving both antibody production and T cell help for effective immunity against NNV.

Quasispecies Dynamics and Virulence

NNV, as an RNA virus, exists as a quasispecies, a cloud of genetically diverse but related variants. This genetic variability is a key driver of virulence and host adaptation. A single point mutation at amino acid 270 of the RGNNV capsid protein can dramatically alter virulence in European sea bass, with the wild-type virus replicating to 1,000-fold higher levels in the brain than the mutant [10]. Importantly, this single mutation in the consensus sequence changes the entire quasispecies structure, affecting the Ts/Tv ratio, recombination frequency, and genetic heterogeneity of the mutant spectrum [10]. This suggests that the virulence of an NNV strain is not solely determined by its consensus sequence but by the dynamic evolution and composition of the entire viral population within the host. The emergence of reassortant strains, such as RGNNV/SJNNV, which combine segments from different genotypes, further complicates the epidemiological landscape and can result in altered host range and virulence, as seen in gilthead sea bream and Senegalese sole [22, 34]. These reassortants can trigger distinct transcriptomic profiles in the host, with more virulent strains inducing a stronger but ultimately dysregulated IFN response [34]. The ability of NNV to rapidly evolve through mutation and reassortment poses a significant challenge for the development of long-lasting vaccines and antiviral strategies.

Epidemiology and Transmission Dynamics

Nervous Necrosis Virus (NNV), a member of the genus Betanodavirus within the family Nodaviridae, represents one of the most formidable viral pathogens confronting global aquaculture and marine fisheries. The epidemiological landscape of NNV is characterized by an extraordinarily broad host range, a global geographic distribution, complex transmission dynamics involving both horizontal and vertical pathways, and the continuous emergence of novel genotypes and reassortant strains. Understanding these intricate patterns is paramount for the development of effective surveillance, biosecurity, and intervention strategies, as the virus is recognized by the World Organisation for Animal Health (WOAH) as a significant threat to aquatic animal health, causing viral encephalopathy and retinopathy (VER), also known as viral nervous necrosis (VNN).

Host Range and Species Susceptibility

The host range of NNV is remarkably extensive, encompassing over 200 species of marine and freshwater fish, and this number continues to expand as surveillance efforts intensify [5, 8, 38]. The virus infects a phylogenetically diverse array of hosts, including members of the Serranidae (groupers), Sparidae (sea bream), Moronidae (sea bass), Pleuronectidae (flatfish), Carangidae (jacks), and Centrarchidae (black sea bass), among many others [3, 23, 25]. The most devastating impacts are observed in larval and juvenile fish, where mortality rates can approach 100%, leading to catastrophic economic losses for hatcheries and nursery operations [1, 8, 15, 43]. The red-spotted grouper nervous necrosis virus (RGNNV) genotype is the most widely distributed and exhibits the broadest range of susceptible species, with an optimal replication temperature that aligns with warmer water conditions [12, 14, 24]. However, the emergence of reassortant strains, such as the RGNNV/SJNNV (striped jack nervous necrosis virus) genotype, has expanded the threat to species previously considered resistant, such as the gilthead sea bream (Sparus aurata), demonstrating the dynamic nature of host-pathogen interactions [22, 25, 31].

Recent investigations have identified NNV in non-traditional hosts, including invertebrates. The detection of RGNNV in cephalopod mollusks (Alloteuthis media and Abralia veranyi) and a decapod crustacean (Plesionika heterocarpus) in the Alboran Sea suggests that these organisms may serve as natural reservoirs or vectors, potentially facilitating the persistence and spread of the virus in the marine environment [12]. Furthermore, rotifers (Brachionus plicatilis) and Artemia nauplii, which are commonly used as live feed for marine fish larvae, have been demonstrated to internalize NNV and transmit the virus horizontally to Senegalese sole (Solea senegalensis) larvae, resulting in significant mortality [40]. This finding underscores a critical, yet often overlooked, route of introduction into aquaculture systems. The susceptibility of ornamental species, such as the big-belly seahorse (Hippocampus abdominalis) and the ocellaris clownfish (Amphiprion ocellaris), further broadens the ecological and economic impact of NNV [13, 64].

Geographic Distribution and Genotypic Diversity

NNV exhibits a truly global distribution, with reports spanning Asia, Europe, the Mediterranean basin, Australia, and the Americas [3, 9, 17-21, 59]. The four major genotypes, RGNNV, SJNNV, barfin flounder nervous necrosis virus (BFNNV), and tiger puffer nervous necrosis virus (TPNNV), are classified based on the sequence of the capsid protein gene (RNA2) and display distinct geographic and thermal preferences [12, 60]. The RGNNV genotype is predominant in warm-water regions, including the Mediterranean and Asia, while BFNNV is associated with colder waters, such as those off the northern Atlantic coast of the United States and Japan [3, 18].

The epidemiological picture is further complicated by the frequent detection of reassortant viruses, which contain genomic segments from different parental genotypes. The RGNNV/SJNNV reassortant, for instance, has become a major concern in Mediterranean aquaculture, infecting European sea bass and gilthead sea bream with varying degrees of virulence [22, 25, 34]. The discovery of a novel genotype, tentatively named black sea bass nervous necrosis virus (BSBNNV), in Centropristis striata from the U.S. Atlantic coast highlights the ongoing evolution and emergence of new viral lineages, even in regions with limited prior surveillance [3]. Similarly, a new genotype has been characterized in Nile tilapia (Oreochromis niloticus) in southern Egypt, demonstrating that NNV is actively circulating and diversifying in freshwater environments as well [9]. The presence of quasispecies, diverse mutant spectra within a single host, further contributes to the virus's adaptive potential. A single point mutation at amino acid 270 of the capsid protein has been shown to dramatically alter the genetic variability and virulence of RGNNV quasispecies in European sea bass, illustrating how minor genetic changes can have profound epidemiological consequences [10].

Transmission Dynamics: Horizontal and Vertical Pathways

The transmission of NNV is a multifaceted process involving both horizontal and vertical routes, each contributing to the virus's persistence and spread within and between populations. Horizontal transmission is considered the primary mechanism for the rapid dissemination of NNV during outbreaks. The virus is shed into the water column from infected fish, with shedding kinetics in sevenband grouper (Hyporthodus septemfasciatus) demonstrating an acute peak within 3–5 days post-infection, followed by a period of diminished shedding and a subsequent secondary increase [62]. The infectious dose for bath challenge was empirically determined to be 10⁵ TCID₅₀/L, and the presence of as few as 10% shedding fish in a population can lead to 100% mortality in naive cohabitants [62]. Water temperature and salinity significantly modulate viral viability in the environment; NNV persistence is highest at 15°C in seawater, with increasing temperatures and higher salinity accelerating viral inactivation [58]. Ultraviolet light and oxygen exposure further reduce viral survival, suggesting that environmental factors play a critical role in transmission efficiency [58].

The gill has been identified as the primary portal of entry for water-borne NNV infection in sevenband grouper, with viral genome and infectious particles detected in gill tissue within hours of bath challenge [50]. Following initial uptake, the virus rapidly traffics to the central nervous system (CNS), crossing the blood-brain barrier to establish infection in the brain and retina, which are the primary target organs [50, 56]. The molecular basis of this neurotropism is linked to the expression of specific host receptors, such as Nectin1 and Nectin4, which are abundant in neural tissues and facilitate viral attachment and entry [35, 68]. The virus also utilizes heat shock proteins, including HSP90ab1 and GHSC70, as part of a receptor complex to mediate clathrin-dependent endocytosis [39, 57]. Once inside the host cell, NNV induces characteristic cytoplasmic vacuolization, a Rab5- and actin-dependent process that is a hallmark of infection and is positively correlated with viral uptake and replication [5, 55].

Vertical transmission is a critical epidemiological feature, enabling the virus to persist across generations and infect naive larvae from the earliest life stages. The detection of NNV in broodstock and its subsequent appearance in fry, as documented in hybrid grouper hatcheries in Malaysia and Thailand, provides strong evidence for this route [31, 37]. The virus can remain latent in asymptomatic adult fish, which act as carriers and shed the virus during stressful periods such as spawning, thereby infecting offspring. This mechanism is particularly insidious, as it allows the virus to circumvent biosecurity measures that focus solely on horizontal transmission. The high prevalence of NNV in wild fish populations, such as the 21.49% prevalence reported in the Levantine Basin, further suggests that wild reservoirs continuously seed the pathogen into the environment, posing a constant threat to adjacent aquaculture operations [69]. Lessepsian migrants (Red Sea species invading the Mediterranean via the Suez Canal) have been shown to carry a significantly higher prevalence of NNV than indigenous species, potentially acting as novel reservoirs and amplifying the risk of spillover into farmed stocks [67].

Risk Factors and Epidemiological Drivers

Several biotic and abiotic factors modulate the epidemiology of NNV, influencing both the likelihood of outbreaks and their severity. Water temperature is a dominant driver, with RGNNV outbreaks typically occurring when temperatures exceed 24°C, while fish reared at suboptimal temperatures (e.g., 17°C) show markedly reduced mortality and can even clear the infection [61]. This temperature-dependent susceptibility is linked to the host's immune response; at lower temperatures, a sustained and stable activation of innate immune factors, including pro-inflammatory cytokines and antiviral genes, is observed, whereas at higher temperatures, a hyperactive immune response resembling a cytokine storm may contribute to pathology [61]. Rearing density is another critical factor; Senegalese sole reared at medium and high densities exhibited earlier mortality onset and higher cumulative mortality following NNV challenge, along with increased viral loads in both fish and water [63]. This effect is likely mediated by stress-induced immunosuppression and enhanced contact rates, although stress biomarkers were not significantly elevated in the study [63]. Coinfections with other pathogens, such as Megalocytivirus ISKNV or Streptococcus species, are common and may exacerbate disease severity, as observed in Asian sea bass and hybrid grouper in Indonesia [65, 66, 69]. Finally, host genetics play a significant role, as demonstrated by genome-wide association studies (GWAS) in leopard coral grouper (Plectropomus leopardus), which identified single nucleotide polymorphisms (SNPs) in genes related to lipid metabolism, oxidative stress, and neuronal survival that are associated with resistance to NNV [7]. Similarly, European sea bass populations from the Eastern Mediterranean exhibit significantly higher odds of survival compared to Atlantic or Western Mediterranean stocks, indicating a heritable component to disease resistance [25].

Clinical Signs and Pathological Features

Nervous necrosis virus (NNV) infection elicits a characteristic and devastating disease syndrome known as viral nervous necrosis (VNN) or viral encephalopathy and retinopathy (VER), a condition recognized by the World Organisation for Animal Health (WOAH) as a significant threat to global aquaculture. The clinical presentation and underlying pathological alterations are profoundly influenced by host species, developmental stage, water temperature, and viral genotype, yet a constellation of hallmark features consistently emerges across susceptible taxa [2, 27, 37, 56]. This section provides an exhaustive examination of the clinical manifestations and pathological features of NNV infection, integrating macroscopic observations, histopathological hallmarks, cellular and molecular pathological mechanisms, and the nuanced variations observed across different host-virus systems.

Behavioral Manifestations and Gross Clinical Signs

The clinical progression of NNV infection is typically acute, particularly in larval and juvenile fish, where mortality can approach 100% within days of exposure [1, 8, 14]. The behavioral repertoire of infected fish reflects the profound neurological dysfunction engendered by viral replication within the central nervous system (CNS). Affected individuals exhibit a stereotyped sequence of aberrant behaviors beginning with lethargy and anorexia, progressing to loss of equilibrium, abnormal spiral or corkscrew swimming patterns, and a characteristic "sleepy" or moribund state during which fish lie motionless at the tank bottom or float listlessly at the water surface [27, 37]. Erratic, darting movements are frequently interspersed with periods of quiescence, and affected fish often display hyperinflation of the swim bladder, contributing to positive buoyancy and an inability to maintain normal posture [37]. Darkening of the skin is a consistently reported gross sign, likely reflecting stress-induced melanophore dispersion or autonomic dysregulation secondary to CNS pathology [27, 37]. In some species, such as hybrid grouper, skeletal deformities including spinal curvature have been documented, particularly in chronic or subacute presentations [31]. It is crucial to recognize that gross external lesions are conspicuously absent; the absence of cutaneous hemorrhages, ulcerations, or fin erosions helps differentiate VNN from many bacterial or parasitic diseases affecting the same hosts [26, 27]. The rapid onset and high mortality, especially in hatchery-reared larvae, often preclude the observation of prodromal signs, with death frequently being the first indication of an outbreak [1, 8, 14].

Histopathological Hallmarks: Vacuolation and Neural Degeneration

The histopathological signature of NNV infection is the presence of severe, widespread cytoplasmic vacuolation within the gray matter of the brain, particularly the midbrain, optic tectum, and medulla oblongata, as well as the retina and spinal cord [2, 13, 37, 56]. This vacuolation is not a random artifact but a highly structured and pathognomonic lesion that directly correlates with viral load and clinical severity. Vacuoles appear as empty, sharply demarcated, circular spaces within the neuropil and neuronal perikarya, ranging in diameter from small, punctate vesicles to large, coalescing cavities exceeding 3 µm in diameter [5, 26]. The vacuolar changes are accompanied by neuronal necrosis characterized by pyknosis, karyorrhexis, and cellular shrinkage, with a concurrent spongiform change in the surrounding neuropil indicating edema and loss of parenchymal integrity [2, 27, 71]. In the retina, vacuolation is observed prominently in the ganglion cell layer and inner nuclear layer, leading to retinal detachment and disorganization in severe cases [13, 27, 37]. Peripheral nerves may also exhibit vacuolar degeneration, underscoring the broad neurotropism of NNV [27].

Critically, the inflammatory response in the CNS is often minimal or absent during acute infection, a feature that distinguishes VNN from many viral encephalitides in mammals. This paucity of leukocytic infiltration reflects the virus's capacity to subvert host immune recognition and the immunoprivileged nature of the CNS [2, 26]. However, in some chronic or recovering infections, particularly in older fish, mild gliosis and perivascular cuffing with lymphocytes may be observed, suggesting a delayed adaptive immune response [27]. The vacuolation itself is now understood to be a dynamic, actively driven process rather than passive cell death. As demonstrated by Liu et al. (2024), RGNNV-induced vacuolization is a Rab5- and actin-dependent process, intimately linked to viral entry and replication [5]. Live-cell imaging revealed that Rab5, a canonical early endosome marker, is continuously recruited to vacuoles during their formation and growth. Furthermore, actin polymerization forms distinct contractile rings around developing small vacuoles, and pharmacological disruption of actin dynamics completely abrogates vacuole formation, whereas microtubule disruption has no effect [5]. This indicates that vacuoles originate from aberrant endosomal maturation and fusion events, hijacked by the virus to create a protected intracellular niche.

Tissue Tropism and Cellular Targets

NNV exhibits a remarkably selective tropism for neural tissues. While the brain and eye are the primary targets, the virus demonstrates a hierarchical pattern of dissemination. Following waterborne exposure, the gill serves as the primary portal of entry, where viral RNA can be detected within hours of challenge [50]. However, the gill does not support robust viral replication; rather, it functions as a conduit for systemic neuroinvasion. The virus subsequently traffics to the brain, likely via the bloodstream or along neural pathways, crossing the blood-brain barrier to establish infection in the brain parenchyma [50]. Within the CNS, single-cell RNA sequencing has refined our understanding of the precise cellular targets. Wang et al. (2021) demonstrated that RGNNV predominantly attacks specific glutamatergic neuronal subtypes (GLU1 and GLU3) in the grouper midbrain, rather than exerting a pan-neuronal effect [56]. This selective vulnerability may be dictated by the differential expression of host factors required for viral entry, such as Nectin1 and Nectin4, which are immunoglobulin-like cell adhesion molecules enriched in neural tissues that function as bona fide attachment and entry receptors for NNV [35, 68]. Nectin1 binds directly to the viral capsid protein (CP) via its IgC1 loop, enabling rapid virion capture and internalization [35]. Similarly, heat shock protein 90ab1 (HSP90ab1) and heat shock cognate protein 70 (HSC70) have been identified as components of the NNV receptor complex, facilitating clathrin-mediated endocytosis [39, 57]. The colocalization of these receptors on neurons explains the exquisite neurotropism of NNV.

Non-neuronal cells in the CNS are also affected. Microglia, the resident macrophages of the brain, undergo significant transcriptional reprogramming upon NNV infection. Pseudotime analysis indicates that microglia transition from a surveillant phenotype to an M1-like pro-inflammatory activated state, producing cytokines in an attempt to curtail viral spread [56]. This microglial activation, while potentially protective, can also contribute to neurotoxicity if dysregulated. Macrophages are enriched in the infected midbrain and display an acute cytokine and inflammatory signature [56]. In contrast, oligodendrocytes and astrocytes show less direct targeting, although their function may be compromised secondary to neuronal injury.

Cellular and Molecular Pathology: From Translation Shutoff to Autophagy

Beyond the macroscopic vacuolation, NNV orchestrates a sophisticated series of cellular pathologies at the molecular level. A seminal feature is host translation shutoff. The viral capsid protein (CP) directly binds to the host polyadenylate-binding protein (PABP), a key translation initiation factor, and induces its nuclear translocalization and subsequent degradation via the ubiquitin-proteasome pathway [38]. This effectively hijacks the host translational machinery, redirecting resources toward viral protein synthesis while simultaneously crippling the production of host antiviral factors. The CP achieves this through a direct interaction between its N-terminal shell domain and the proline-rich linker region of PABP [38].

Autophagy is another critical pathway subverted by NNV. The virus induces incomplete autophagy in infected cells, characterized by the formation of autophagosomes that fail to fuse with lysosomes, thereby avoiding degradation [36, 41]. This process is triggered by the binding of RGNNV CP to cell surface HSP90ab1, which inactivates the HSP90ab1-AKT-MTOR pathway by competitively displacing AKT from its interaction with HSP90ab1 [36]. The resulting inhibition of MTOR signaling relieves the brake on autophagy initiation. Paradoxically, the virus exploits this autophagic flux to enhance its own replication; inhibiting autophagy significantly reduces viral titers, while inducing autophagy promotes them [41]. This mechanism allows NNV to create membrane-bound replication platforms while evading lysosomal destruction.

Apoptosis is differentially modulated during NNV infection. Early in infection, the virus actively suppresses apoptosis to allow sufficient time for replication. The nonstructural protein B2, an early expressed protein detected as soon as 3 hours post-infection, acts as a potent inhibitor of host transcription by targeting Ser5-phosphorylated RNA polymerase II, thereby dampening the expression of pro-apoptotic and interferon-stimulated genes [8, 11, 24]. Concurrently, the virus upregulates host factors like TRAF4 and NLRC3, which attenuate interferon signaling and NF-κB activation, further blocking pro-apoptotic pathways [45, 48]. However, at later stages of infection, when viral progeny have been assembled, the virus induces apoptosis to facilitate viral release and spread. MicroRNA profiling has identified cal-miR-155 as a pro-apoptotic factor that is significantly upregulated in NNV-infected brain cells, and its overexpression enhances apoptosis and inhibits viral replication, suggesting a host countermeasure that the virus must carefully balance [47].

Variability in Pathology by Genotype, Host, and Environmental Factors

The pathological picture of NNV infection is not monolithic. Different genotypes exhibit distinct virulence and tissue tropism patterns. The RGNNV genotype is the most widespread and virulent, causing high mortality across a broad range of warm-water marine species, whereas the SJNNV genotype is more restricted in host range and often less pathogenic [10, 20, 25]. Reassortant strains, such as RGNNV/SJNNV, can exhibit intermediate or even enhanced virulence, as demonstrated in Senegalese sole where a reassortant caused 100% mortality compared to lower rates with parental genotypes [34]. A single amino acid change at position 270 of the capsid protein (serine to asparagine) has been identified as a critical virulence determinant in sea bass, dramatically affecting viral load and quasispecies diversity in the brain [10].

Host species and age profoundly influence pathology. Larval and juvenile fish are exquisitely susceptible, often exhibiting acute, peracute disease with minimal histological change before death, whereas adult fish may act as asymptomatic carriers with chronic, low-level infection confined to the brain [25, 70]. In species like gilthead sea bream, long considered resistant, the emergence of reassortant strains has now made them susceptible, with transcriptomic studies revealing downregulation of interferon and innate immune pathways as a potential mechanism for their initial resistance [22]. Temperature is a critical environmental modulator. Clinical outbreaks typically occur at water temperatures above 24°C, while at suboptimal temperatures below 20°C, fish are often refractory to disease. This thermoregulation is linked to the temperature-dependent activity of viral RNA polymerase and the differential expression of host immune factors such as STAT1, STAT3, and SOCS proteins [61]. High rearing density further exacerbates pathology by increasing viral shedding, waterborne viral load, and stress-mediated immunosuppression, leading to earlier mortality onset and higher cumulative mortality [63].

Advanced Diagnostic Methods for NNV Detection

The accurate and timely detection of Nervous Necrosis Virus (NNV) is paramount for implementing effective biosecurity measures, managing outbreaks, and mitigating the substantial economic losses inflicted upon global aquaculture. Traditional diagnostic approaches, including virus isolation in cell culture and conventional reverse transcription-polymerase chain reaction (RT-PCR), while foundational, are increasingly recognized as insufficient for the demands of modern, high-throughput, and field-based surveillance. Cell culture, although considered a gold standard for viable virus detection, is labor-intensive, time-consuming (often requiring 7–14 days for cytopathic effect development), and necessitates specialized laboratory infrastructure and technical expertise [26, 73]. Similarly, conventional RT-PCR, while more rapid, requires thermocycling equipment and post-amplification processing, posing contamination risks and limiting its utility in pond-side settings [1]. The emergence of highly sensitive, specific, and rapid diagnostic platforms, particularly those leveraging isothermal amplification, CRISPR-based technologies, and novel affinity ligands, has revolutionized the landscape of NNV detection, enabling a shift from centralized laboratory testing to real-time, on-site surveillance.

Nucleic Acid Amplification Technologies: From qRT-PCR to Isothermal and CRISPR-Based Platforms

Quantitative real-time RT-PCR (RT-qPCR) remains the most widely adopted molecular diagnostic for NNV, offering high sensitivity, specificity, and the capacity for viral load quantification. A validated SYBR Green-based RT-qPCR protocol has demonstrated a limit of detection (LOD) as low as 2.36 plasmid copies per reaction and 8.8 TCID₅₀/mL, with superior diagnostic sensitivity and specificity compared to nested PCR and cell culture isolation [60]. This method is particularly valuable for quantifying viral RNA in field samples, enabling risk assessment and monitoring of viral kinetics in both clinical and subclinical infections. The assay's high repeatability and reproducibility, irrespective of the calibration standard (plasmid, in vitro transcribed RNA, or purified virus), ensure reliable inter-laboratory comparisons, a critical feature for standardized surveillance programs [60]. However, the reliance on expensive thermocyclers and trained personnel limits its deployment in resource-limited aquaculture settings.

To overcome these barriers, isothermal amplification methods have emerged as powerful alternatives. Reverse transcription-recombinase aided amplification (RT-RAA) operates at a constant temperature (typically 37–42°C), eliminating the need for thermal cycling. When coupled with the CRISPR/Cas12a system, this technology achieves both signal amplification and specific target recognition. A landmark study by Gao et al. (2025) developed a dual-CRISPR/Cas12a-assisted RT-RAA visualization system targeting two distinct NNV genomic segments: the capsid protein (CP) gene on RNA2 and the RNA-dependent RNA polymerase (RdRp) gene on RNA1 [1]. This dual-targeting strategy is a critical innovation, as it reduces the risk of false negatives arising from genomic reassortment or mutation, a known phenomenon in NNV evolution [3, 10, 31]. The system operates within a single tube, completing the reaction in under 30 minutes with a remarkable LOD of 0.5 copies/μL. Validation against 32 field samples demonstrated 100% concordance with qRT-PCR, confirming its diagnostic accuracy [1]. The use of fluorescence intensity for readout, interpretable by the naked eye, makes this platform ideally suited for pond-side deployment by fish farm personnel, enabling immediate intervention decisions.

Serological and Immunochromatographic Assays for Rapid Field Diagnosis

While nucleic acid-based methods offer exquisite sensitivity, serological and immunochromatographic assays provide the advantages of simplicity, speed, and low cost, making them indispensable for rapid screening in the field. Lateral flow immunoassays (LFIAs) have been developed using monoclonal antibodies (mAbs) conjugated to colloidal gold nanoparticles. Shyam et al. (2020) reported an LFIA using mAb 2B1 as the detector and mAb 2B11 as the capture antibody, achieving a LOD of 10⁵·⁰⁵ TCID₅₀/100 μL with results visible within 10 minutes [76]. Field validation using brain tissue from RGNNV-infected sevenband grouper demonstrated 100% specificity and 94.92% sensitivity, with a diagnostic effectiveness of 96.81% [76]. Similarly, Hassantabar et al. (2021) developed a colloidal gold immunochromatography strip test for golden grey mullet, achieving 100% specificity and 74% sensitivity compared to RT-qPCR, with a LOD of approximately 10³ TCID₅₀/mL [72]. The lower sensitivity of these antibody-based methods compared to molecular assays is a recognized trade-off; however, their operational simplicity, requiring no equipment beyond the strip itself, positions them as valuable first-line screening tools, particularly in hatcheries and remote farming sites where laboratory access is limited.

Aptamer-based lateral flow biosensors (LFBs) represent a further refinement of this technology, substituting antibodies with synthetic oligonucleotide ligands that offer superior stability, lower production costs, and batch-to-batch consistency. Liu et al. (2020) developed an LFB combining aptamer-based magnetic bead enrichment with isothermal strand displacement amplification (SDA) for the detection of RGNNV capsid protein. This system achieved a LOD of 5 ng/mL of CP protein or 5 × 10³ RGNNV-infected grouper brain cells, with results observable by the naked eye within 5 minutes [75]. The integration of an amplification step bridges the sensitivity gap between antibody-based strips and molecular methods, while maintaining the user-friendly format. Furthermore, aptamers selected via Cell-SELEX technology have been shown to specifically recognize RGNNV-infected cells and tissues, with dissociation constants (Kd) as low as 27.96 nM, and can be harnessed for targeted delivery of therapeutic siRNAs, demonstrating a dual diagnostic-therapeutic potential [74].

Advanced Molecular Characterization: In Situ Hybridization and Next-Generation Sequencing

Beyond detection and quantification, advanced diagnostic methods are essential for characterizing NNV strains, understanding pathogenesis, and tracking viral evolution. In situ hybridization (ISH) provides spatial resolution of viral RNA within host tissues, offering insights into cellular tropism and the progression of infection. Using RNA probes targeting both RNA1 and RNA2 segments, Kim et al. (2019) demonstrated that RNA1 is detectable as early as 6 hours post-infection in SSN-1 cells, preceding the detection of viral particles by immunocytochemistry at 24 hours [42]. This temporal disparity suggests that RNA1, encoding the RdRp, is transcribed early in the replication cycle, while RNA2, encoding the CP, is expressed later, a finding consistent with the sequential nature of viral replication. In field samples, ISH using NNV-specific probes has localized viral RNA within vacuolation lesions of the brain, spinal cord, and retina of infected fish, confirming the neurotropic nature of the virus and providing a direct link between molecular detection and histopathological changes [37, 50].

Next-generation sequencing (NGS) has emerged as a powerful tool for characterizing NNV quasispecies dynamics and identifying virulence determinants. Campo et al. (2023) employed NGS to analyze the genetic variability of RGNNV quasispecies in European sea bass infected with recombinant viruses differing by a single amino acid substitution (S270N) in the capsid protein. The study revealed that the low-virulence mutant exhibited a 1,000-fold reduction in viral load and distinct quasispecies characteristics, including altered transition-to-transversion ratios and recombination frequencies [10]. This finding underscores that even a single nucleotide change can profoundly reshape the mutant spectrum of a bisegmented RNA virus, with direct implications for virulence and host adaptation. Moreover, NGS has facilitated the discovery of novel NNV genotypes, such as the black sea bass nervous necrosis virus (BSBNNV) identified along the U.S. Atlantic coast, and a new genotype circulating among Nile tilapia in southern Egypt [3, 9]. These discoveries highlight the ongoing evolution and geographic expansion of NNV, emphasizing the need for continuous genomic surveillance to inform vaccine development and biosecurity strategies.

Emerging Technologies: Affinity Peptides, Nanobodies, and Plant-Based Production Systems

The frontier of NNV diagnostics is being shaped by innovative biorecognition elements and production platforms. Affinity peptides (AFPs) selected from phage display libraries offer a synthetic alternative to antibodies, with the advantages of small size, chemical stability, and ease of production. Zhou et al. (2019) identified a dodecapeptide (12C) that binds specifically to orange-spotted grouper NNV virus-like particles (VLPs), causing virion aggregation and blocking viral entry into host cells. A recombinant fusion protein, MBP-triple-12C (MBP-T12C), exhibited broad-spectrum binding across all NNV serotypes, demonstrating its potential as a universal diagnostic capture reagent [78]. The ability to produce such peptides in prokaryotic systems at low cost makes them attractive for large-scale diagnostic kit manufacturing.

Variable lymphocyte receptors (VLRBs) from jawless vertebrates, such as hagfish, represent another novel class of recognition molecules. Jung et al. (2019) developed NNV-specific VLRBs through library screening and modular engineering, achieving a 250-fold increase in binding affinity after domain swapping. These VLRBs neutralized NNV infectivity in vitro and in vivo, positioning them as both diagnostic and therapeutic agents [77]. The unique structure of VLRBs, based on leucine-rich repeat modules, provides a scaffold distinct from conventional immunoglobulins, potentially enabling recognition of epitopes inaccessible to antibodies.

Finally, plant-based production systems offer a scalable and cost-effective platform for generating diagnostic antigens and virus-like particles (VLPs). Marsian et al. (2019) demonstrated that transient expression of Atlantic cod NNV coat protein in Nicotiana benthamiana plants yielded VLPs that self-assembled into T=3 particles, morphologically identical to native virions as confirmed by cryo-electron microscopy [28]. These plant-produced VLPs, when administered to sea bass, conferred protection against subsequent viral challenge, highlighting their dual utility as vaccines and as standardized antigens for diagnostic assays. The ability to produce immunologically relevant NNV antigens in plants circumvents the biosafety concerns and high costs associated with mammalian cell culture, aligning with the principles of sustainable aquaculture health management.

In summary, the diagnostic armamentarium for NNV has expanded dramatically, encompassing a spectrum of technologies from validated RT-qPCR protocols and rapid immunochromatographic strips to cutting-edge CRISPR-based systems and NGS-based genomic surveillance. The selection of an appropriate diagnostic method must be guided by the specific context: high-throughput laboratory confirmation for epidemiological studies, rapid pond-side tests for outbreak response, and advanced molecular characterization for understanding viral evolution and pathogenesis. The integration of these diverse platforms, coupled with the development of novel biorecognition elements, promises to enhance our capacity to detect, monitor, and ultimately control this devastating pathogen, aligning with the World Organisation for Animal Health (WOAH) standards for aquatic animal health surveillance.

Prevention, Control, and Management Strategies

The multifaceted challenge posed by Nervous Necrosis Virus (NNV) to global aquaculture demands a similarly multi-layered approach to prevention, control, and management. Given the virus’s ability to cause catastrophic mortality rates approaching 100% in larval and juvenile fish, its broad host range encompassing over 120-200 species, and its capacity for both horizontal and vertical transmission, a reliance on any single intervention is demonstrably insufficient [6, 8, 37, 38]. An integrated strategy, often referred to as a comprehensive health management program, must be deployed, incorporating enhanced biosecurity, rigorous surveillance using advanced diagnostics, strategic immunoprophylaxis, selective breeding for genetic resistance, and environmental management to mitigate risk factors.

Enhanced Surveillance and Rapid On-Site Diagnostics

The cornerstone of any effective NNV control program is the capacity for early, accurate, and rapid detection. Traditional methods such as cell culture isolation and conventional RT-PCR, while valuable, are hampered by their time-consuming nature, requirement for specialized laboratory infrastructure, and the inherent risk of contamination during sample transport and processing [1]. The latency of NNV, where asymptomatic carriers can shed virus into the environment, makes early detection particularly challenging yet critically important [62]. Consequently, recent innovations have focused on developing point-of-care (POND-SIDE) diagnostic tools that empower farmers and field veterinarians to make immediate management decisions.

The most cutting-edge development in this arena is the dual-CRISPR/Cas12a-assisted reverse transcription-recombinase aided amplification (RT-RAA) visualization system [1]. This system represents a paradigm shift in NNV diagnostics by enabling the simultaneous detection of two viral genes, the capsid protein (CP) and RNA-dependent RNA polymerase (RdRp), within a single, 30-minute reaction. With a detection limit of 0.5 copies/μL and 100% accuracy compared to qRT-PCR in field samples, this technology offers unprecedented sensitivity and specificity at the pond-side [1]. The use of fluorescence intensity for result interpretation minimizes the need for subjective judgment by field operators, reducing the likelihood of false negatives and facilitating timely intervention to quarantine infected stocks before a full-blown outbreak ensues [1].

Complementing these molecular advances are immunochromatographic and aptamer-based lateral flow biosensors (LFBs) that provide a simpler, instrument-free visual readout. Colloidal gold immunochromatography test strips, utilizing monoclonal and polyclonal antibodies, can detect NNV within 15 minutes with a specificity of 100% and a sensitivity of 74% compared to real-time RT-PCR in naturally infected fish [72]. Alternative LFB designs employing aptamers for target recognition, combined with isothermal strand displacement amplification, have demonstrated the ability to detect as little as 5 ng/mL of RGNNV-CP protein [75]. These systems are ideal for rapid screening of broodstock, incoming fry, and the rearing environment, directly supporting control efforts by identifying and segregating infected populations. The development and deployment of these robust, simple, low-cost, and accurate methods are critical for effective disease monitoring and environmental safety at the farm level [76, 81].

Vaccine Development and Immunoprophylaxis

Given the acute and rapidly progressive nature of NNV-induced disease, prophylactic vaccination is a highly desirable control strategy. However, the immature adaptive immune system of fish larvae, which are the most susceptible age class, presents a significant hurdle [70, 78]. Despite this, substantial progress has been made in developing a variety of vaccine platforms, each with distinct advantages and limitations.

Recombinant Protein and Virus-Like Particle (VLP) Vaccines: Subunit vaccines, particularly those based on the immunogenic capsid protein (CP), have shown considerable promise. A VLP-based vaccine for European sea bass provided high and superior survival in experimental challenges conducted 3 and 7.5 months post-vaccination, with relative percent survival (RPS) values of 87 and 88, respectively [23]. Importantly, this platform induced a broad immune response, including upregulation of both innate (mx, isg12) and adaptive (mhc I, mhc II, igm, igt) components, and elicited high titers of neutralizing antibodies that persisted for at least 9 months [23]. The production of VLPs can also be achieved in plant-based systems, using Nicotiana benthamiana or transgenic tobacco BY-2 cells, offering a scalable and cost-effective manufacturing alternative that protects fish against subsequent virus challenge [28].

DNA Vaccines: DNA vaccines encoding CP have demonstrated potent efficacy. A bicistronic DNA vaccine co-expressing CP and the immune adjuvant interferon regulatory factor 3 (IRF3) in pearl gentian grouper resulted in a robust humoral and cellular response, with RPS values of 81.25%, 73.91%, and 66.67% after challenge with 10^5, 10^6, or 10^7 TCID50/fish, respectively [46]. This strategy leverages the ability of DNA vaccines to stimulate both MHC class I and class II pathways, leading to the induction of cytotoxic T lymphocytes and neutralizing antibodies [46].

Oral Vaccines with Adjuvants: Oral delivery is highly desirable for vaccinating large numbers of fry in a stress-free manner. A key advance involves using the live feed Artemia as a biocarrier for recombinant CP fused with grouper β-defensin (DEFB) as a molecular adjuvant. This CP-DEFB oral vaccine induced higher levels of anti-RGNNV CP-specific antibodies and neutralization potency than CP alone, culminating in a 100% RPS in pearl gentian grouper after RGNNV challenge [6]. The β-defensin adjuvant likely enhances the immunogenicity of the CP antigen by activating innate immune pathways, thereby overcoming the poor immunogenicity often associated with oral antigen delivery [6].

Passive Immunization: As an alternative to active vaccination, particularly for high-value broodstock or during immediate outbreak threats, passive immunization using specific yolk antibodies (IgY) has been evaluated. Feeding mandarin fish with diets supplemented with anti-MFNNV IgY for 7 days prior to virus challenge resulted in a 36% relative protection rate compared to controls, accompanied by significantly reduced viral gene expression in the brain and eyes, and decreased immune-related pathology [43]. While this approach does not confer long-term immunity, it provides a valuable, rapid intervention strategy.

Antiviral Compounds and Therapeutic Interventions

While prevention is paramount, the development of antiviral therapeutics provides a crucial second line of defense for treating infected stocks or as a prophylactic during high-risk periods. Several promising compounds have been identified through both in vitro and in vivo studies.

Oleanolic Acid (OA): OA, a natural triterpenoid, demonstrated significant anti-NNV activity in vitro, achieving a 99.97% inhibition rate at 10.95 μM, likely through the inhibition of NNV-induced apoptosis [79]. In vivo, OA treatment of grouper resulted in a 30% survival rate compared to only 10% in the control group, and was associated with upregulation of immune gene expression and effective suppression of NNV replication in the host [79]. This suggests OA could be developed as a feed additive to bolster antiviral immunity.

Affinity Peptides (AFPs): A highly innovative approach involves the use of short, synthetic affinity peptides that directly bind to viral particles. A dodecapeptide (12C) selected against NNV virus-like particles (VLPs) was shown to agglutinate or disrupt virion particles, thereby blocking viral entry into host cells [78]. A recombinant fusion protein, MBP-triple-12C, exhibited broad-spectrum anti-NNV activity against all serotypes tested, demonstrating the therapeutic potential of blocking the initial stages of infection [78].

Host-Targeted Antivirals: Another strategic avenue is to block host factors that are essential for viral entry. Computer-aided drug design has identified potential inhibitors, such as compounds from Azadirachta indica (Neem), that bind strongly to the grouper heat shock cognate protein 70 (GHSC70), a known NNV receptor, thereby blocking the virus’s ability to enter host cells [57]. Similarly, aptamer-siRNA conjugates, designed to specifically target RGNNV-infected cells, have shown remarkable efficacy in vitro, reducing viral infection by approximately 75% after 48 hours through targeted delivery of small interfering RNAs [74]. These approaches hold great promise for delivering potent antiviral molecules directly to the sites of infection.

Biosecurity, Environmental Management, and Genetic Selection

A sustainable, long-term strategy for NNV control must extend beyond direct antiviral interventions to encompass farm management practices and selective breeding.

Biosecurity and Quarantine: Given that NNV can be transmitted vertically from broodstock and horizontally via contaminated water, feed, and fomites, strict biosecurity is non-negotiable [31, 40]. The detection of NNV in wild fish and invertebrates, such as squid and shrimp in the Alboran Sea, underscores the risk of spillover from wild reservoirs into aquaculture facilities [12, 69]. Therefore, sourcing fry from certified NNV-free hatcheries, quarantining new stock, and treating incoming water (e.g., with UV or ozone) are critical first steps. Rearing density is a significant risk factor; higher densities in Senegalese sole led to earlier mortality onset and higher cumulative mortality following NNV infection, likely due to increased viral shedding and stress-mediated immunosuppression [63]. The role of live feed as a vector is also critical; Artemia nauplii can bioaccumulate NNV and transmit the infection to larvae, causing high mortality [40]. Consequently, sourcing live feed from reliable sources and treating it to inactivate potential viral contamination is essential.

Environmental Control: NNV viability in the water column is strongly modulated by abiotic factors. Viral persistence is highest at 15°C in seawater, with a significant drop in viability as temperatures increase [58]. At 15 and 30°C, survival was strongly affected by high salt content, while UV light and oxygen exposure accelerated inactivation [58]. These findings suggest that manipulating water temperature (e.g., short-term elevation) and exposure to UV light could be viable management tools to reduce environmental viral load, particularly during hatchery operations. The suboptimal immune response at higher temperatures, potentially involving a "cytokine storm" that causes pathology, must also be considered when designing temperature-based management strategies [61].

Genetic Selection for Resistance: Perhaps the most elegant and sustainable long-term strategy is the selective breeding of fish with enhanced genetic resistance to NNV. This approach is supported by compelling evidence that host genetics play a major role in disease outcome. A genome-wide association study (GWAS) in leopard coral grouper identified 18 SNP loci linked to NNV resistance, including candidate genes such as sik2, herc2, and npr1, which are involved in lipid metabolism, oxidative stress, and neuronal survival [7]. Crucially, transcriptomic analyses of naturally resistant versus susceptible fish have revealed that resistance is associated with the upregulation of neuroprotective and repair mechanisms and the suppression of hyperactive inflammatory responses, suggesting that a balanced immune response, rather than a maximal one, is key to survival [2, 80]. Furthermore, population-level studies in European sea bass have demonstrated significant differences in survival odds among Atlantic and Mediterranean populations, with an Eastern Mediterranean stock having 3.32 times higher odds of surviving an NNV challenge [25]. The identification of these genetic markers and the characterization of fundamental resistance mechanisms provide a solid foundation for marker-assisted selection (MAS) programs. By incorporating these markers into breeding goals, it is possible to develop domesticated grouper and sea bass lines with inherent, heritable resistance, reducing the need for chemical or biological interventions.

References

[1] Gao J, Huang S, Jiang J, Miao Q, Zheng R, Kang Y, et al.. Dual-CRISPR/Cas12a-assisted RT-RAA visualization system for rapid on-site detection of nervous necrosis virus (NNV).. Analytica Chimica Acta. 2025. DOI: https://doi.org/10.1016/j.aca.2024.343469

[2] Wang J, Yu X, Song S, Zhang Y, Cao J, Jin C, et al.. Transcriptome analysis reveals the immune responses of leopard coral grouper to nervous necrosis virus infection.. Fish and Shellfish Immunology. 2025. DOI: https://doi.org/10.1016/j.fsi.2025.110290

[3] Lovy J, Abbadi M, Toffan A, Das N, Neugebauer J, Batts W, et al.. Detection and Genetic Characterization of Red-Spotted Grouper Nervous Necrosis Virus and a Novel Genotype of Nervous Necrosis Virus in Black Sea Bass from the U.S. Atlantic Coast. Viruses. 2025. DOI: https://doi.org/10.3390/v17091234

[4] Huang S, Yang L, Zheng R, Weng S, He J, Xie J. Nervous necrosis virus capsid protein and Protein A dynamically modulate the fish cGAS-mediated IFN signal pathway to facilitate viral evasion. Journal of Virology. 2024. DOI: https://doi.org/10.1128/jvi.00686-24

[5] Liu J, Wang L, Zhang X, Wang S, Qin Q. Nervous necrosis virus induced vacuolization is a Rab5- and actin-dependent process. Virulence. 2024. DOI: https://doi.org/10.1080/21505594.2023.2301244

[6] Zheng J, Yang J, Zhang Z, Liang X, Liu S, Pan Y, et al.. An improved oral vaccine with molecular adjuvant β-defensin protects grouper against nervous necrosis virus infection.. Fish and Shellfish Immunology. 2023. DOI: https://doi.org/10.1016/j.fsi.2023.108709

[7] Wang J, Yu X, Wu S, Jin C, Wang M, Ding H, et al.. Identification of candidate SNPs and genes associated with resistance to nervous necrosis virus in leopard coral grouper (Plectropomus leopardus) using GWAS.. Fish and Shellfish Immunology. 2023. DOI: https://doi.org/10.1016/j.fsi.2023.109295

[8] Qin Y, Zhang P, Deng S, Guo W, Zhang M, Liu H, et al.. Red-grouper nervous necrosis virus B1 protein inhibits fish IFN response by targeting Ser5-phosphorylated RNA polymerase II to promote viral replication.. Fish and Shellfish Immunology. 2023. DOI: https://doi.org/10.1016/j.fsi.2023.108578

[9] Gherbawy Y, Thabet MA, Sultan S. Genetic and morphological characterization of a new genotype of nervous necrosis virus circulating among Nile tilapia in the south of Egypt. International Microbiology. 2023. DOI: https://doi.org/10.1007/s10123-023-00406-5

[10] Campo SO, Díaz-Martínez L, Moreno P, García-Rosado E, Alonso MC, Bejar J, et al.. The genetic variability and evolution of red-spotted grouper nervous necrosis virus quasispecies can be associated with its virulence. Frontiers in Microbiology. 2023. DOI: https://doi.org/10.3389/fmicb.2023.1182695

[11] Zhang Y, Dong F, Xing J, Tang X, Sheng X, Chi H, et al.. Characterization of Nervous Necrosis Virus (NNV) Nonstructural Protein B2 and Its Enhancement on Virus Proliferation. Viruses. 2022. DOI: https://doi.org/10.3390/v14122818

[12] Johnstone C, Pérez M, Arizcun M, García-Ruíz C, Chaves-Pozo E. Reservoirs of Red-Spotted Grouper Nervous Necrosis Virus (RGNNV) in Squid and Shrimp Species of Northern Alboran Sea. Viruses. 2022. DOI: https://doi.org/10.3390/v14020328

[13] Chen X, Qi J, He L, Luo H, Lin J, Qiu F, et al.. Isolation and identification of a new strain of nervous necrosis virus from the big-belly seahorse Hippocampus abdominalis. Virology Journal. 2022. DOI: https://doi.org/10.1186/s12985-022-01837-8

[14] Lei Y, Xiong Y, Tao D, Wang T, Chen T, Du X, et al.. Construction of Attenuated Strains for Red-Spotted Grouper Nervous Necrosis Virus (RGNNV) via Reverse Genetic System. Viruses. 2022. DOI: https://doi.org/10.3390/v14081737

[15] Joshi A, Pathak D, Mannan M, Kaushik V. In-silico designing of epitope-based vaccine against the seven banded grouper nervous necrosis virus affecting fish species. Network Modeling Analysis in Health Informatics and Bioinformatics. 2021. DOI: https://doi.org/10.1007/s13721-021-00315-5

[16] Gye H, Nishizawa T. Sites responsible for infectivity and antigenicity on nervous necrosis virus (NNV) appear to be distinct. Scientific Reports. 2021. DOI: https://doi.org/10.1038/s41598-021-83078-3

[17] . striped jack nervous necrosis virus. CABI Compendium. 2022. DOI: https://doi.org/10.1079/cabicompendium.69410

[18] . barfin flounder nervous necrosis virus. CABI Compendium. 2022. DOI: https://doi.org/10.1079/cabicompendium.92283

[19] . Japanese flounder nervous necrosis virus. CABI Compendium. 2022. DOI: https://doi.org/10.1079/cabicompendium.78459

[20] . redspotted grouper nervous necrosis virus. CABI Compendium. 2022. DOI: https://doi.org/10.1079/cabicompendium.66800

[21] . Malabar grouper nervous necrosis virus. CABI Compendium. 2022. DOI: https://doi.org/10.1079/cabicompendium.76245

[22] Peruzza L, Pascoli F, Rovere GD, Franch R, Ferraresso S, Babbucci M, et al.. Transcriptome analysis reveals a complex response to the RGNNV/SJNNV reassortant Nervous Necrosis Virus strain in sea bream larvae.. Fish and Shellfish Immunology. 2021. DOI: https://doi.org/10.1016/j.fsi.2021.04.021

[23] Barsøe S, Skovgaard K, Sepúlveda D, Stratmann A, Vendramin N, Lorenzen N. Nervous Necrosis Virus-like Particle (VLP) Vaccine Stimulates European Sea Bass Innate and Adaptive Immune Responses and Induces Long-Term Protection against Disease. Pathogens. 2021. DOI: https://doi.org/10.3390/pathogens10111477

[24] Qin Y, Wang Y, Liu J, Lu Y, Liu X. Red-grouper nervous necrosis virus B2 protein negatively regulates fish interferon response by suppressing host transcription directed by RNA polymerase II. Aquaculture. 2021. DOI: https://doi.org/10.1016/J.AQUACULTURE.2021.736488

[25] Barsøe S, Allal F, Vergnet A, Vandeputte M, Olesen NJ, Schmidt J, et al.. Different survival of three populations of European sea bass (Dicentrarchus labrax) following challenge with two variants of nervous necrosis virus (NNV). Aquaculture Reports. 2021. DOI: https://doi.org/10.1016/J.AQREP.2021.100621

[26] Qin Y, Liu J, Liu W, Shi H, Jia A, Lu Y, et al.. First isolation and identification of red-grouper nervous necrosis virus (RGNNV) from adult hybrid Hulong grouper (Epinephelus fuscoguttatus × Epinephelus lanceolatus) in China. Aquaculture. 2020. DOI: https://doi.org/10.1016/j.aquaculture.2020.735662

[27] Xing J, Zhang Z, Sheng X, Tang X, Chi H, Zhan W. Identification and characterization of a new strain of nervous necrosis virus isolated from pearl gentian grouper (Epinephelus lanceolatus × Epinephelus fuscoguttatus) in China. Aquaculture. 2020. DOI: https://doi.org/10.1016/j.aquaculture.2020.735663

[28] Marsian J, Hurdiss DL, Ranson N, Ritala A, Paley R, Cano I, et al.. Plant-Made Nervous Necrosis Virus-Like Particles Protect Fish Against Disease. Frontiers in Plant Science. 2019. DOI: https://doi.org/10.3389/fpls.2019.00880

[29] Huang P, Hsiao H, Wang S, Lo S, Lu M, Chen L. Screening for the Proteins That Can Interact with Grouper Nervous Necrosis Virus Capsid Protein. Viruses. 2020. DOI: https://doi.org/10.3390/v12090985

[30] Gye H, Nishizawa T. Altered conformational structures of nervous necrosis virus surface protrusions and free coat proteins after incubation at moderate-low temperatures. Scientific Reports. 2019. DOI: https://doi.org/10.1038/s41598-019-45094-2

[31] Ariff N, Abdullah A, Azmai MNA, Musa N, Zainathan SC. Risk factors associated with viral nervous necrosis in hybrid groupers in Malaysia and the high similarity of its causative agent nervous necrosis virus to reassortant red-spotted grouper nervous necrosis virus/striped jack nervous necrosis virus strains. Veterinary World. 2019. DOI: https://doi.org/10.14202/vetworld.2019.1273-1284

[32] Gye H, Nishizawa T. Treatment with carbonate buffer decreases antigenicity of nervous necrosis virus (NNV). Aquaculture. 2019. DOI: https://doi.org/10.1016/J.AQUACULTURE.2018.10.010

[33] Zainathan SC, Ariff N. Nodavirosis (Striped jack nervous necrosis virus).. . 2020. DOI: https://doi.org/10.1079/9781789243277.0085

[34] Labella A, García-Rosado E, Bandín I, Dopazo C, Castro D, Alonso MC, et al.. Transcriptomic Profiles of Senegalese Sole Infected With Nervous Necrosis Virus Reassortants Presenting Different Degree of Virulence. Frontiers in Immunology. 2018. DOI: https://doi.org/10.3389/fimmu.2018.01626

[35] Zhang Z, Xing J, Tang X, Sheng X, Chi H, Zhan W. Nectin1 is a pivotal host factor involved in attachment and entry of red-spotted grouper nervous necrosis virus in the early stages of the viral life cycle. Journal of Virology. 2024. DOI: https://doi.org/10.1128/jvi.00901-24

[36] Zhang W, Jia P, Lu X, Chen X, Weng J, Jia K, et al.. Capsid protein from red-spotted grouper nervous necrosis virus induces incomplete autophagy by inactivating the HSP90ab1-AKT-MTOR pathway. Zoological Research. 2022. DOI: https://doi.org/10.24272/j.issn.2095-8137.2021.249

[37] Jungi SV, Sangsuriya P, Taengphu S, Phiwsaiya K, Sonthi M, Nuangsaeng B, et al.. Detection of nervous necrosis virus RGNNV genotype in pearl gentian grouper (Epinephelus lanceolatus ♂ × E. fuscoguttatus ♀) fry imported to Thailand. bioRxiv. 2022. DOI: https://doi.org/10.1101/2022.02.24.481889

[38] Cheng C, Luo J, Chiang M, Fang K, Li C, Chen C, et al.. Nervous Necrosis Virus Coat Protein Mediates Host Translation Shutoff through Nuclear Translocalization and Degradation of Polyadenylate Binding Protein. Journal of Virology. 2021. DOI: https://doi.org/10.1128/JVI.02364-20

[39] Zhang W, Jia K, Jia P, Xiang Y, Lu X, Liu W, et al.. Marine medaka heat shock protein 90ab1 is a receptor for red-spotted grouper nervous necrosis virus and promotes virus internalization through clathrin-mediated endocytosis. PLoS Pathogens. 2020. DOI: https://doi.org/10.1371/journal.ppat.1008668

[40] Vázquez-Salgado L, Olveira JG, Dopazo C, Bandín I. Role of rotifer (Brachionus plicatilis) and Artemia (Artemia salina) nauplii in the horizontal transmission of a natural nervous necrosis virus (NNV) reassortant strain to Senegalese sole (Solea senegalensis) larvae. Veterinary Quarterly. 2020. DOI: https://doi.org/10.1080/01652176.2020.1810357

[41] Li C, Liu J, Zhang X, Yu Y, Huang X, Wei J, et al.. Red grouper nervous necrosis virus (RGNNV) induces autophagy to promote viral replication.. Fish and Shellfish Immunology. 2019. DOI: https://doi.org/10.1016/j.fsi.2019.11.053

[42] Kim J, Kim W, Oh M. Investigation of nervous necrosis virus (NNV) replication in vitro using RNA in situ hybridization.. Virus Research. 2019. DOI: https://doi.org/10.1016/j.virusres.2018.11.011

[43] Liang Z, Ning Y, Cao J, Liu S, Liang X, Peng X, et al.. The protective effect of specific yolk antibody against Nervous necrosis virus infection in Mandarin fish(Siniperca chuatsi).. Fish and Shellfish Immunology. 2024. DOI: https://doi.org/10.1016/j.fsi.2024.109996

[44] Zhang W, Yao L, Chen L, Jia P, Xiang Y, Yi M, et al.. Ring Finger Protein 34 Facilitates Nervous Necrosis Virus Evasion of Antiviral Innate Immunity by Targeting TBK1 and IRF3 for Ubiquitination and Degradation in Teleost Fish. Journal of Virology. 2023. DOI: https://doi.org/10.1128/jvi.00533-23

[45] Krishnan R, Rajendran R, Jang Y, Kim J, Yoon S, Oh M. NLRC3 attenuates antiviral immunity and activates inflammasome responses in primary grouper brain cells following nervous necrosis virus infection.. Fish and Shellfish Immunology. 2022. DOI: https://doi.org/10.1016/j.fsi.2022.06.026

[46] Lin T, Xing J, Tang X, Sheng X, Chi H, Zhan W. Development and Evaluation of a Bicistronic DNA Vaccine against Nervous Necrosis Virus in Pearl Gentian Grouper (Epinephelus lanceolatus × Epinephelus fuscoguttatus). Vaccines. 2022. DOI: https://doi.org/10.3390/vaccines10060946

[47] Du H, Cao Z, Liu Z, Wang G, Wu Y, Du X, et al.. Cromileptes altivelis microRNA Transcriptome Analysis upon Nervous Necrosis Virus (NNV) Infection and the Effect of cal-miR-155 on Cells Apoptosis and Virus Replication. Viruses. 2022. DOI: https://doi.org/10.3390/v14102184

[48] Wu S, Sun M, Zhang X, Liao J, Liu M, Qin Q, et al.. Grouper TRAF4, a Novel, CP-Interacting Protein That Promotes Red-Spotted Grouper Nervous Necrosis Virus Replication. International Journal of Molecular Sciences. 2021. DOI: https://doi.org/10.3390/ijms22116136

[49] Xiang Y, Zhang W, Jia P, Lu X, Liu W, Yi M, et al.. E3 Ubiquitin Ligase RNF114 Inhibits Innate Immune Response to Red-Spotted Grouper Nervous Necrosis Virus Infection in Sea Perch by Targeting MAVS and TRAF3 to Mediate Their Degradation.. Journal of Immunology. 2020. DOI: https://doi.org/10.4049/jimmunol.2000083

[50] Krishnan R, Kim J, Qadiri SSN, Kim J, Oh M. Early viral uptake and host-associated immune response in the tissues of seven-band grouper following a bath challenge with nervous necrosis virus.. Fish and Shellfish Immunology. 2020. DOI: https://doi.org/10.1016/j.fsi.2020.05.012

[51] Xiang Y, Jia P, Liu W, Yi M, Jia K. Comparative transcriptome analysis reveals the role of p53 signalling pathway during red‐spotted grouper nervous necrosis virus infection in Lateolabrax japonicus brain cells. Journal of Fish Diseases. 2019. DOI: https://doi.org/10.1111/jfd.12960

[52] Jung J, Chun JH, Lee JS, Kim SW, Lee AR, Kim J, et al.. Characterization of CD4-Positive Lymphocytes in the Antiviral Response of Olive Flounder (Paralichthys oliveceus) to Nervous Necrosis Virus. International Journal of Molecular Sciences. 2020. DOI: https://doi.org/10.3390/ijms21114180

[53] Asim M, Asim M, Babu VS, Qin Z, Zhao L, Su J, et al.. Inhibition of Cyclophilin A on the replication of red spotted grouper nervous necrosis virus associates with multiple pro-inflammatory factors. Fish and Shellfish Immunology. 2019. DOI: https://doi.org/10.1016/j.fsi.2019.05.064

[54] Krishnan R, Kurcheti P, Mushtaq Z, K. J, T. VN. Interferon‐regulatory factors, IRF3 and IRF7 in Asian seabass, Lates calcarifer: Characterization, ontogeny and transcriptional modulation upon challenge with nervous necrosis virus. Fish and Shellfish Immunology. 2019. DOI: https://doi.org/10.1016/j.fsi.2019.03.073

[55] Guo X, Wang W, Zheng Q, Qin Q, Huang Y, Huang X. Comparative transcriptomic analysis reveals different host cell responses to Singapore grouper iridovirus and red-spotted grouper nervous necrosis virus.. Fish and Shellfish Immunology. 2022. DOI: https://doi.org/10.1016/j.fsi.2022.07.068

[56] Wang Q, Peng C, Yang M, Huang F, Duan X, Wang S, et al.. Single-cell RNA-seq landscape midbrain cell responses to red spotted grouper nervous necrosis virus infection. PLoS Pathogens. 2021. DOI: https://doi.org/10.1371/journal.ppat.1009665

[57] Islam SI, Saloa S, Mahfuj S, Islam MJ, Mou M. Computer-aided drug design of Azadirachta indica compounds against nervous necrosis virus by targeting grouper heat shock cognate protein 70 (GHSC70): quantum mechanics calculations and molecular dynamic simulation approaches. Genomics & Informatics. 2022. DOI: https://doi.org/10.5808/gi.21063

[58] Vázquez-Salgado L, Olveira JG, Bandín I. Nervous necrosis virus viability modulation by water salinity and temperature.. Journal of Fish Diseases. 2022. DOI: https://doi.org/10.1111/jfd.13581

[59] . tiger puffer nervous necrosis virus. CABI Compendium. 2022. DOI: https://doi.org/10.1079/cabicompendium.61128

[60] Olveira JG, Souto S, Bandín I, Dopazo C. Development and Validation of a SYBR Green Real Time PCR Protocol for Detection and Quantification of Nervous Necrosis Virus (NNV) Using Different Standards. Animals. 2021. DOI: https://doi.org/10.3390/ani11041100

[61] Krishnan R, Jang Y, Kim J, Oh M. Altered expression of immune factors in sevenband grouper, Hyporthodus septemfasciatus following nervous necrosis virus challenge at optimal and suboptimal temperatures.. Fish and Shellfish Immunology. 2021. DOI: https://doi.org/10.1016/j.fsi.2021.10.033

[62] Krishnan R, Qadiri SSN, Kim J, Oh M. Infection dynamics and shedding kinetics of nervous necrosis virus in juvenile seven band grouper using an intraperitoneal infection-cohabitation model. Aquaculture. 2021. DOI: https://doi.org/10.1016/J.AQUACULTURE.2020.735957

[63] Vázquez-Salgado L, Olveira JG, Dopazo C, Bandín I. Effect of rearing density on nervous necrosis virus infection in Senegalese sole (Solea senegalensis).. Journal of Fish Diseases. 2021. DOI: https://doi.org/10.1111/jfd.13514

[64] Yashwanth BS, Goswami M, Valappil RK, Thakuria D, Chaudhari A. Characterization of a new cell line from ornamental fish Amphiprion ocellaris (Cuvier, 1830) and its susceptibility to nervous necrosis virus. Scientific Reports. 2020. DOI: https://doi.org/10.1038/s41598-020-76807-7

[65] Jitrakorn S, Gangnonngiw W, Bunnontae M, Manajit O, Rattanarojpong T, Chaivisuthangkura P, et al.. Infectious cell culture system for concurrent propagation and purification of Megalocytivirus ISKNV and nervous necrosis virus from Asian Sea bass (Lates calcarifer). Aquaculture. 2020. DOI: https://doi.org/10.1016/j.aquaculture.2020.734931

[66] Putra BS, Hick P, Hall E, Whittington R, Khairul R, Evarianti, et al.. Prevalence of Infectious Spleen and Kidney Necrosis Virus (ISKNV), Nervous Necrosis Virus (NNV) and Ectoparasites in Juvenile Epinephelus spp. Farmed in Aceh, Indonesia. Pathogens. 2020. DOI: https://doi.org/10.3390/pathogens9070578

[67] Lampert Y, Berzak R, Davidovich N, Diamant A, Stern N, Scheinin A, et al.. Indigenous versus Lessepsian Hosts: Nervous Necrosis Virus (NNV) in Eastern Mediterranean Sea Fish. Viruses. 2020. DOI: https://doi.org/10.3390/v12040430

[68] Krishnan R, Qadiri SSN, Oh M. Functional characterization of seven-band grouper immunoglobulin like cell adhesion molecule, Nectin4 as a cellular receptor for nervous necrosis virus.. Fish and Shellfish Immunology. 2019. DOI: https://doi.org/10.1016/j.fsi.2019.08.019

[69] Berzak R, Scheinin A, Davidovich N, Regev Y, Diga R, Tchernov D, et al.. Prevalence of nervous necrosis virus (NNV) and Streptococcus species in wild marine fish and crustaceans from the Levantine Basin, Mediterranean Sea.. Diseases of Aquatic Organisms. 2019. DOI: https://doi.org/10.3354/DAO03339

[70] Ge H, Lin K, Zhou C, Lin Q, Zhang Z, Wu J, et al.. A multi-omic analysis of orange-spotted grouper larvae infected with nervous necrosis virus identifies increased adhesion molecules and collagen synthesis in the persistent state.. Fish and Shellfish Immunology. 2020. DOI: https://doi.org/10.1016/j.fsi.2020.01.056

[71] Yu Q, Liu M, Wei S, Xiao H, Wu S, Qin X, et al.. Isolation of Nervous Necrosis Virus from Hybrid Grouper (Epinephelus fuscoguttatus♀ × Epinephelus lanceolatus♂) Cultured in Guangxi, China. Gyobyo kenkyu - Fish pathology. 2019. DOI: https://doi.org/10.3147/JSFP.54.16

[72] Hassantabar F, Zorriehzahra M, Firouzbakhsh F, Thompson K. Development and evaluation of colloidal gold immunochromatography test strip for rapid diagnosis of nervous necrosis virus in golden grey mullet (Chelon aurata).. Journal of Fish Diseases. 2021. DOI: https://doi.org/10.1111/jfd.13302

[73] Valero Y, López-Vázquez C, Souto S, Olveira JG, Cuesta A, Bandín I. Differential Nervous Necrosis Virus (NNV) Replication in Five Putative Susceptible Cell Lines. Pathogens. 2021. DOI: https://doi.org/10.3390/pathogens10121565

[74] Zhou L, Wang S, Yu Q, Wei S, Liu M, Wei J, et al.. Characterization of Novel Aptamers Specifically Directed to Red-Spotted Grouper Nervous Necrosis Virus (RGNNV)-Infected Cells for Mediating Targeted siRNA Delivery. Frontiers in Microbiology. 2020. DOI: https://doi.org/10.3389/fmicb.2020.00660

[75] Liu J, Qin Q, Zhang X, Li C, Yu Y, Huang X, et al.. Development of a Novel Lateral Flow Biosensor Combined With Aptamer-Based Isolation: Application for Rapid Detection of Grouper Nervous Necrosis Virus. Frontiers in Microbiology. 2020. DOI: https://doi.org/10.3389/fmicb.2020.00886

[76] Shyam K, Jeong H, Oh M, Kim C, Kim W. Development of a lateral flow immuno-chromatic strip assay for the detection of nervous necrosis virus (NNV, RGNNV genotype). Aquaculture. 2020. DOI: https://doi.org/10.1016/j.aquaculture.2020.734944

[77] Jung J, Lee JS, Kim J, Im S, Kim SW, Lazarte J, et al.. Characterization of Hagfish (Eptatretus burgeri) Variable Lymphocyte Receptor–Based Antibody and Its Potential Role in the Neutralization of Nervous Necrosis Virus. Journal of Immunology. 2019. DOI: https://doi.org/10.4049/jimmunol.1900675

[78] Zhou QL, Zhang J, Huang R, Huang S, Wu Y, Huang L, et al.. An affinity peptide exerts antiviral activity by strongly binding nervous necrosis virus to block viral entry. Fish and Shellfish Immunology. 2019. DOI: https://doi.org/10.1016/j.fsi.2018.12.003

[79] Liu Q, Liu X, Yang B, Liu T, Yu Q, Ling F, et al.. Evaluation of anti-Nervous Necrosis Virus activity of Oleanolic Acid in vitro and in vivo.. Fish and Shellfish Immunology. 2024. DOI: https://doi.org/10.1016/j.fsi.2024.109847

[80] Toubanaki DK, Efstathiou A, Karagouni E. Transcriptomic Analysis of Fish Hosts Responses to Nervous Necrosis Virus. Pathogens. 2022. DOI: https://doi.org/10.3390/pathogens11020201

[81] Toubanaki DK, Margaroni M, Prapas A, Karagouni E. Development of a Nanoparticle-based Lateral Flow Strip Biosensor for Visual Detection of Whole Nervous Necrosis Virus Particles. Scientific Reports. 2020. DOI: https://doi.org/10.1038/s41598-020-63553-z